Achilles Therapeutics PLC (ACHL)
1.03
0.00 (0.00%)
USD |
NASDAQ |
Nov 05, 16:00
1.03
0.00 (0.00%)
After-Hours: 18:06
Achilles Therapeutics Net Income (Quarterly): -16.38M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -16.38M |
| March 31, 2024 | -12.27M |
| December 31, 2023 | -18.63M |
| September 30, 2023 | -16.68M |
| June 30, 2023 | -16.85M |
| March 31, 2023 | -17.51M |
| December 31, 2022 | -24.06M |
| September 30, 2022 | -12.48M |
| June 30, 2022 | -17.29M |
| Date | Value |
|---|---|
| March 31, 2022 | -17.36M |
| December 31, 2021 | -18.23M |
| September 30, 2021 | -12.95M |
| June 30, 2021 | -16.16M |
| March 31, 2021 | -13.76M |
| December 31, 2020 | -12.92M |
| September 30, 2020 | -8.21M |
| June 30, 2020 | -6.855M |
| March 31, 2020 | -5.214M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-24.06M
Minimum
Dec 2022
-5.214M
Maximum
Mar 2020
-14.66M
Average
-16.27M
Median
Net Income (Quarterly) Benchmarks
| Autolus Therapeutics PLC | -58.27M |
| Biodexa Pharmaceuticals PLC | -- |
| Centessa Pharmaceuticals PLC | -43.82M |
| Adaptimmune Therapeutics PLC | 69.52M |
| Verona Pharma PLC | -70.84M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 17.80M |
| EPS Diluted (Quarterly) | -0.41 |
| Enterprise Value | -53.00M |
| Earnings Yield | -154.4% |